
Organometallics
Organometallic compounds are those that contain bonds between carbon atoms and metals, usually transition metals such as magnesium, zinc, or platinum. These compounds exhibit a wide structural and chemical diversity, giving them high reactivity. They are mainly used in organic synthesis, catalysing reactions such as monomer polymerisation and carbon-carbon bond formation. Additionally, organometallic compounds have applications in the pharmaceutical industry, including the manufacture of anticancer drugs, as well as in industrial processes such as plastic and fuel production.
At CymitQuimica, we offer a wide range of organometallic compounds for research in organic chemistry, catalysis, and the synthesis of new materials.
Found 4401 products of "Organometallics"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(2-Butoxy-4-fluorophenyl)boronic acid
CAS:Formula:C10H14BFO3Purity:95.0%Color and Shape:SolidMolecular weight:212.03Transplatin
CAS:<p>Applications Transplatin is the trans stereoisomer impurity of Cisplatin (C499500), an antineoplastic used in the treatment of sarcomas, some carcinomas, lymphomas, and germ cell tumors. Transplatin binds to DNA but does not exhibit the same useful pharmacological effect as its cis stereoisomer.<br>References Cersosimo, R.J.: Cancer Treat. Rev., 16, 195 (1989); Takeiri, A. et al.: Genes Environ., 29, 89 (2007); Giraud-Panis, M.-J. et al.: Pharmacol. Therap., 85, 175 (2000);<br></p>Formula:Cl2H6N2PtColor and Shape:Light YellowMolecular weight:300.045-(Acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications An intermediate used in the synthesis of imaging agents such as Iohexol (I729500).<br>References Priebe, H., et al.: J. Clin. Pharm. Ther., 24, 227 (1999),<br></p>Formula:C16H20I3N3O7Color and Shape:NeatMolecular weight:747.06Carboplatin
CAS:<p>Applications Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.<br>References Harland, S.J., et al.: Cancer Res., 44, 1693 (1984), Smith, I.E., et al.: Cancer Treat. Rep., 69, 43 (1985), Lygidakis, N.J., et al.: Interferon Cytokine Res., 15, 467 (1995),<br></p>Formula:C6H12N2O4PtColor and Shape:White To Off-WhiteMolecular weight:371.25(2-Ethoxy-4-methylpyridin-3-yl)boronic acid
CAS:Purity:95+%Color and Shape:SolidMolecular weight:181.03-(Methoxycarbonyl)thiophene-2-boronic acid
CAS:Purity:95%Color and Shape:SolidMolecular weight:185.99000549316406(3-((4-Chlorophenoxy)methyl)phenyl)boronic acid
CAS:Formula:C13H12BClO3Purity:95.0%Color and Shape:SolidMolecular weight:262.54-Borono-2,6-difluorobenzoic acid
CAS:Formula:C7H5BF2O4Purity:98%Color and Shape:No data available.Molecular weight:201.92(5,6-Difluoropyridin-3-yl)boronic acid
CAS:Formula:C5H4BF2NO2Purity:96%Color and Shape:No data available.Molecular weight:158.9(3-(Piperidin-1-yl)phenyl)boronic acid
CAS:Formula:C11H16BNO2Purity:97%Color and Shape:SolidMolecular weight:205.06[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN') Diiodoplatinum
CAS:<p>Applications [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN')diiodoplatinum is a potential antitumor agent. Impurity of Oxiplatin (O845075), third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y. et al.: Biomed. Pharmacther., 43, 261 (1989); Noji, M. et al.: J. Med. Chem., 24, 508 (1981); Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C6H14I2N2PtColor and Shape:NeatMolecular weight:563.083-Chloro-4-pyridineboronic acid hydrate
CAS:Formula:C5H7BClNO3Purity:95.0%Color and Shape:SolidMolecular weight:175.38(3-Methoxypyridin-4-yl)boronic acid hydrate
CAS:Formula:C6H10BNO4Purity:95.0%Color and Shape:SolidMolecular weight:170.96

